Sonja Nelson

Currently holds a position at Immunitybio Inc

Position	Company	Period
Chief Financial Officer	Immunitybio Inc	June 11, 2018 -
Chief Accounting Officer	Immunitybio Inc	May 1, 2016 - June 1, 2018

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2023-10-31	2023-10-27	Ambrx Biopharma Cayman Inc (AMAM)	PlS Planned sale	81,705 -47.0% 95.03 US$803,224	81,705 -47.0%	95.03	US$803,224
2023-10-27	2023-10-27	Ambrx Biopharma Cayman Inc (AMAM)	PrS Proposed sale	86,857 447.95 US$71,547	86,857	447.95	US$71,547
2021-01-13	2021-01-12	Immunitybio Inc (IBRX)	PlS Planned sale	82,627 -16.6% 241.97 US$4,549,902	82,627 -16.6%	241.97	US$4,549,902
2021-01-06	2021-01-04	Immunitybio Inc (IBRX)	PlS Planned sale	39,271 -65.8% 13.62 US$534,938	39,271 -65.8%	13.62	US$534,938